These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection. Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Silvestri C; Orlando F; Mocchegiani F; Vittoria AD; Kamysz E; Saba V; Scalise G Peptides; 2007 Jun; 28(6):1299-303. PubMed ID: 17537542 [TBL] [Abstract][Full Text] [Related]
23. Oligomerization of RNAIII-Inhibiting Peptide Inhibits Adherence and Biofilm Formation of Methicillin-Resistant Staphylococcus aureus In Vitro and In Vivo. Zhou Y; Zhao R; Ma B; Gao H; Xue X; Qu D; Li M; Meng J; Luo X; Hou Z Microb Drug Resist; 2016 Apr; 22(3):193-201. PubMed ID: 26571297 [TBL] [Abstract][Full Text] [Related]
24. Weak effect of metal type and ica genes on staphylococcal infection of titanium and stainless steel implants. Hudetz D; Ursic Hudetz S; Harris LG; Luginbühl R; Friederich NF; Landmann R Clin Microbiol Infect; 2008 Dec; 14(12):1135-45. PubMed ID: 19046165 [TBL] [Abstract][Full Text] [Related]
25. Telavancin: in vitro activity against staphylococci in a biofilm model. Gander S; Kinnaird A; Finch R J Antimicrob Chemother; 2005 Aug; 56(2):337-43. PubMed ID: 15972312 [TBL] [Abstract][Full Text] [Related]
26. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis. Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Skerlavaj B; Licci A; Balaban N; Zanetti M; Scalise G; Saba V Shock; 2006 Sep; 26(3):296-301. PubMed ID: 16912656 [TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo antibiofilm activity of a coral associated actinomycete against drug resistant Staphylococcus aureus biofilms. Bakkiyaraj D; Pandian SK Biofouling; 2010 Aug; 26(6):711-7. PubMed ID: 20706890 [TBL] [Abstract][Full Text] [Related]
28. Quorum sensing-mediated regulation of staphylococcal virulence and antibiotic resistance. Singh R; Ray P Future Microbiol; 2014; 9(5):669-81. PubMed ID: 24957093 [TBL] [Abstract][Full Text] [Related]
29. Foreign body infections due to Staphylococcus epidermidis. Uçkay I; Pittet D; Vaudaux P; Sax H; Lew D; Waldvogel F Ann Med; 2009; 41(2):109-19. PubMed ID: 18720093 [TBL] [Abstract][Full Text] [Related]
30. Nosocomial infections by Staphylococcus epidermidis: how a commensal bacterium turns into a pathogen. Ziebuhr W; Hennig S; Eckart M; Kränzler H; Batzilla C; Kozitskaya S Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S14-20. PubMed ID: 16829054 [TBL] [Abstract][Full Text] [Related]
31. A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. Balaban N; Gov Y; Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Orlando F; D'Amato G; Saba V; Scalise G; Bernes S; Mor A Antimicrob Agents Chemother; 2004 Jul; 48(7):2544-50. PubMed ID: 15215107 [TBL] [Abstract][Full Text] [Related]
32. Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors. Kiran MD; Giacometti A; Cirioni O; Balaban N Int J Artif Organs; 2008 Sep; 31(9):761-70. PubMed ID: 18924087 [TBL] [Abstract][Full Text] [Related]
33. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms. Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828 [TBL] [Abstract][Full Text] [Related]
34. RIP-V improves murine survival in a sepsis model by down-regulating RNAIII expression and α-hemolysin release of methicillin-resistant Staphylococcus aureus. Ma B; Zhou Y; Li M; Yu Q; Xue X; Li Z; Da F; Hou Z; Luo X Pharmazie; 2015 Feb; 70(2):81-7. PubMed ID: 25997246 [TBL] [Abstract][Full Text] [Related]
35. Higher biofilm formation in multidrug-resistant clinical isolates of Staphylococcus aureus. Kwon AS; Park GC; Ryu SY; Lim DH; Lim DY; Choi CH; Park Y; Lim Y Int J Antimicrob Agents; 2008 Jul; 32(1):68-72. PubMed ID: 18534827 [TBL] [Abstract][Full Text] [Related]
36. Organic compounds inhibiting S. epidermidis adhesion and biofilm formation. Qin Z; Zhang J; Hu Y; Chi Q; Mortensen NP; Qu D; Molin S; Ulstrup J Ultramicroscopy; 2009 Jul; 109(8):881-8. PubMed ID: 19375859 [TBL] [Abstract][Full Text] [Related]
37. Slime production by Staphylococci isolated from prosthesis-associated infections. Arciola CR; Montanaro L; Baldassarri L; Borsetti E; Cavedagna D; Donati E New Microbiol; 1999 Oct; 22(4):337-41. PubMed ID: 10555204 [TBL] [Abstract][Full Text] [Related]
38. [Are we being threatened by multiresistant strains of Staphylococcus aureus?]. Aepfelbacher M MMW Fortschr Med; 2005 Jan; 147(4):33-5, 37. PubMed ID: 15745339 [TBL] [Abstract][Full Text] [Related]
39. Berberine inhibits Staphylococcus epidermidis adhesion and biofilm formation on the surface of titanium alloy. Wang X; Qiu S; Yao X; Tang T; Dai K; Zhu Z J Orthop Res; 2009 Nov; 27(11):1487-92. PubMed ID: 19472377 [TBL] [Abstract][Full Text] [Related]
40. Activity of sodium metabisulfite against planktonic and biofilm Staphylococcus species. Frank KL; Patel R Diagn Microbiol Infect Dis; 2007 Apr; 57(4):355-9. PubMed ID: 17188446 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]